Epoetin alfa biosimilar (LG Life Sciences)

阿法依伯汀生物类似药 (LG Life Sciences)

Report date: 2026/03/26 20:00:17

Base Information

Drug NameEpoetin alfa biosimilar (LG Life Sciences)
Drug Alias NameEpoetina alfa (LG Life Sciences)依泊汀α生物仿制药 (LG Life Sciences)阿法依伯汀生物仿制药 (LG Life Sciences)Epoetinum alfa (LG Life Sciences)促红素α生物仿制药 (LG Life Sciences) +[9
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsMyelodysplastic SyndromesAnemiaCardiovascular Diseases +[6
Global Approved IndicationsAnemia
Approved Indications in ChinaAnemia
Original Approved Country/TerritoryMainland China
Original Approved Date2017/01/01
Country/TerritoryUnited StatesSouth KoreaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A

Develop Information

Active IndicationsMyelodysplastic SyndromesAnemiaLeukemia, Myelomonocytic, Chronic
Inactive IndicationsCardiovascular DiseasesBrain IschemiaCerebral Palsy

Other Information

ATC CodeB03XA01
Related LinksN/A